Assertio’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Arthur J Higgins's photo - President & CEO of Assertio

President & CEO

Arthur J Higgins

CEO Approval Rating

90/100

Founded:

1995

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Cambia Health Solutions is a top competitor of Assertio. Cambia Health Solutions was founded in Portland, Oregon} in 1996. Cambia Health Solutions competes in the Life & Health Insurance industry. Compared to Assertio, Cambia Health Solutions generates $9.3B more revenue.

Arbor Pharmaceuticals is Assertio's #2 competitor. Arbor Pharmaceuticals is headquartered in Atlanta, Georgia, and was founded in 2006. Arbor Pharmaceuticals competes in the Pharmaceuticals field. Arbor Pharmaceuticals generates 90% the revenue of Assertio.

ZOMIG has been one of Assertio's top competitors. ZOMIG is a Private company that was founded in null in , . ZOMIG operates in the industry. Compared to Assertio, ZOMIG has NaN fewer employees.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 125 a good estimate for Assertio's Employee count?

Acquisitions

No recent acquisitions found related to Assertio

Assertio Funding History

$7.2M$19.5M$39.5M$43.3M$43.8M$618.8M

Since Assertio was founded in 1995, it has participated in 6 rounds of funding. In total Assertio has raised $618.8M. Assertio's last funding round was on Mar 2015 for a total of $575.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Mar 2015
$575M
Grant
Nov 2010
$489K
-
Debt
Jun 2008
$3.8M

Oxford Finance

Private Placement
Apr 2003
$20M

MDS Capital

Equity
Jun 2001
$12.3M

Total Funding: $618.8M

Since Assertio was founded in 1995, it has participated in 6 rounds of funding. In total Assertio has raised $618.8M. Assertio's last funding round was on Mar 2015 for a total of $575.0M

Investments

No recent investments found related to Assertio

Assertio News

August 7, 2020NewsOk

2Q Earnings Snapshot

LAKE FOREST, Ill. (AP) _ Assertio Holdings, Inc.Read more on NewsOK.com... See more »
August 7, 2020Benzinga

Assertio Reports Second Quarter 2020 Financial Results

--Completed all merger and integration activities in Q2----Repaid $10 million of Senior Secured Notes... See more »
June 16, 2020Zolmax News

Assertio Therapeutics (ASRT) & Its Peers Financial Contrast

Assertio Therapeutics (NASDAQ: ASRT) is one of 616 publicly-traded companies in the "Pharmaceutical p... See more »
May 20, 2020BioSpace

Assertio Completed Merger with Zyla Life Sciences

Trading under ASRT on Nasdaq Global Select Market Combined Company Pro Forma 2019 Net Product Sales o... See more »
May 11, 2020BioSpace

Assertio Therapeutics Announces First-Quarter 2020 Results

-- Completed Strategic Asset Sales of NUCYNTA ® Franchise and Gralise ® Totaling $502.5 Million -- --... See more »

Assertio Press Releases

February 19, 2019StreetInsider

Assertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin

Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that it has received notification of accep... See more »
January 9, 2019StreetInsider

Assertio Therapeutics Announces Amendment of its Senior Secured Credit Facility

Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has amended its Senior Secured Cre... See more »
December 20, 2018GlobeNewswire

Assertio Therapeutics Announces Submission of NDA for FDA Approval of Cosyntropin Depot

-- Submission Advances Company's Strategy to Build A New Orphan/Specialty Business and Aligns with Co... See more »
November 8, 2018GlobeNewswire

Assertio Therapeutics Announces Third-Quarter 2018 Financial Results

-- Confirms Full-Year Net Sales Guidance Range for the Neurology Franchise ---- Raises Full-Year Earn... See more »
July 6, 2018GlobeNewswire

Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LAKE FOREST, Ill., July 06, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced that effec... See more »
May 7, 2018EconoTimes

Depomed to Present at the UBS Global Healthcare Conference

Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate at the... See more »

Headquarters

100 South Saunders Road Suite 300

Lake Forest, Illinois60045

224-419-7106

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Assertio was founded in 1995. Assertio's headquarters is located in Lake Forest, Illinois, USA 60045. It has raised 618.8M in 6 rounds. The latest round was in Mar 2015. Some of Assertio's investors include Deerfield Capital Management, Pharmakon Adv...

CEO

Assertio's President & CEO, Arthur J Higgins, currently has an approval rating of 90%. Assertio's primary competitors are Cambia Health Solutions, Arbor Pharmaceuticals & ZOMIG.

Website

assertiotx.com

Frequently Asked Questions about Assertio

  1. When was Assertio founded?

    Assertio was founded in 1995
  2. Who is Assertio's CEO?

    Assertio's CEO is Arthur J Higgins
  3. How much revenue does Assertio generate?

    Assertio generates $192.5M in revenue
  4. How much funding does Assertio have?

    Assertio has historically raised $618.8M in funding
  1. Where is Assertio's headquarters?

    Assertio's headquarters is in Lake Forest Illinois, USA
  2. How many employees does Assertio have?

    Assertio has 125 employees
  3. What sector does Assertio operate in?

    Assertio is in Pharmaceuticals
  4. Who are Assertio's competitors?

    Assertio's top competitors are Cambia Health Solutions, Arbor Pharmaceuticals, ZOMIG